bupropion has been researched along with Obstructive Lung Diseases in 8 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of bupropion-induced drug rash with eosinophilia and systemic symptoms syndrome, including acute hepatitis, obstructive lung disease, and myositis." | 7.72 | Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. ( Bagshaw, SM; Bowen, TJ; Cload, B; Gilmour, J; Leung, ST, 2003) |
| "Bupropion SRis a well-tolerated and effective aid to smoking cessation in people with mild to moderate COPD." | 5.09 | Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. ( Anderson, P; Bailey, W; Buist, S; Dozier, G; Gonzales, D; Jamerson, B; Kanner, R; Nides, M; Patel, MK; Tashkin, D, 2001) |
| "To report a case of bupropion-induced drug rash with eosinophilia and systemic symptoms syndrome, including acute hepatitis, obstructive lung disease, and myositis." | 3.72 | Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. ( Bagshaw, SM; Bowen, TJ; Cload, B; Gilmour, J; Leung, ST, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagshaw, SM | 1 |
| Cload, B | 1 |
| Gilmour, J | 1 |
| Leung, ST | 1 |
| Bowen, TJ | 1 |
| Rennard, SI | 1 |
| Daughton, DM | 1 |
| Petty, TL | 1 |
| Tashkin, D | 1 |
| Kanner, R | 1 |
| Bailey, W | 1 |
| Buist, S | 1 |
| Anderson, P | 1 |
| Nides, M | 1 |
| Gonzales, D | 1 |
| Dozier, G | 1 |
| Patel, MK | 1 |
| Jamerson, B | 1 |
| Wagena, EJ | 1 |
| Huibers, MJ | 1 |
| van Schayck, CP | 1 |
| García-Río, F | 1 |
| Serrano, S | 1 |
| Mediano, O | 1 |
| Alonso, A | 1 |
| Villamor, J | 1 |
| Cox, A | 1 |
| Anton, C | 1 |
| Campbell, IA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "A Randomized Open-label, Superiority, Multicenter, Two-arm Intervention Study of the Effect of High-intensity vs. 'Low-intensity' Smoking Cessation Intervention in Active Smokers With COPD"[NCT04088942] | Phase 4 | 0 participants (Actual) | Interventional | 2023-07-01 | Withdrawn (stopped due to No funding) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for bupropion and Obstructive Lung Diseases
| Article | Year |
|---|---|
Smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Humans; Lung Diseases, Obstru | 2000 |
1 trial available for bupropion and Obstructive Lung Diseases
| Article | Year |
|---|---|
Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Confidence Intervals; Dose-Respons | 2001 |
6 other studies available for bupropion and Obstructive Lung Diseases
| Article | Year |
|---|---|
Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Canada; Eosinophilia; Exanthema; Hepatit | 2003 |
COPD. Interventions for smoking cessation and improved ventilatory function.
Topics: Antidepressive Agents, Second-Generation; Bronchodilator Agents; Bupropion; Disease Progression; Hum | 2000 |
Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression.
Topics: Antidepressive Agents; Bupropion; Depressive Disorder; Humans; Lung Diseases, Obstructive; Nortripty | 2001 |
Safety profile of bupropion for chronic obstructive pulmonary disease.
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Lung Diseases, Obstructive; Randomized Controlled Tri | 2001 |
Safety profile of bupropion for chronic obstructive pulmonary disease.
Topics: Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Lung Diseases, Obstructive; | 2001 |
Safety profile of bupropion for chronic obstructive pulmonary disease.
Topics: Bupropion; Clinical Trials as Topic; Counseling; Dopamine Uptake Inhibitors; Humans; Lung Diseases, | 2001 |